urmc.rochester.edu
Sep 17, 2026, 14:23
Neil Blumberg: ABO Nonidentical Transfusions and Mortality in Massive Transfusion
Neil Blumberg, Professor, Director of Transfusion Medicine/Blood Bank at University of Rochester Medical Center, shared a post on LinkedIn, about a recent article, he and his colleagues co-authored, published in Jama Surgery, adding:
“ABO mismatched transfusions likely harm patients experiencing severe hemorrhage undergoing massive transfusion protocol”
Title: ABO Nonidentical Transfusions and Mortality in Patients Undergoing Massive Transfusion Protocol
Authores: Neil Blumberg, Kelly Henrichs, Debra Masel, Michael Vella, Mark Gestring, Amanda Lippa, Phuong-Lan Nguyen, Akua Asante, Christine Cahill, Majed Refaai
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 17, 2026, 14:21Jay Mohan: Thrombectomy and Balloon Angioplasty for Pacemaker-Induced Thrombosis
-
Sep 17, 2026, 14:03Thomas Pincez: Estimating the Effect of Fetal Hemoglobin on Sickle Cell Trait Using Polygenic Scores
-
Sep 17, 2026, 13:52Ashley George: Blood Clots Remain the Leading Cause of Maternal Death in UK
-
Sep 17, 2026, 13:09Mehak Trehan: New Perspectives on Anemia Management in CKD
-
Sep 17, 2026, 10:08WFH 2027 Comprehensive Care Summit Opens Abstract Submissions – World Federation of Hemophilia
-
Sep 17, 2026, 09:56Marianne Yee: MySCDstory Expands Access to Multilingual Sickle Cell Education
-
Sep 17, 2026, 09:36Enewa Onoja: Platelet Satellitism Phenomenon, Three Misleading Counts
-
Sep 17, 2026, 09:22Emmanuel J Favaloro: Hemostasis and Thrombosis in Exercise and Athletes
-
Sep 17, 2026, 09:18Updated Iron Deficiency Diagnostic Guidelines – American Society of Hematology